Filter
1702
Filtered Results: 1702
Text search:
European
Medicines
Agency
Featured
Recommendations
157
New Publications
353
Language
Document type
No document type
801
Studies & Reports
402
Guidelines
247
Manuals
105
Strategic & Response Plan
56
Fact sheets
38
Training Material
22
Situation Updates
20
Resource Platforms
5
Brochures
3
App
1
Infographics
1
Online Courses
1
Countries / Regions
Western and Central Europe
94
Global
87
Ukraine
55
Eastern Europe
35
Africa
30
Kenya
28
Ethiopia
25
Sierra Leone
22
Nigeria
21
Ghana
21
Zambia
21
Liberia
20
Germany
19
Myanmar / Burma
19
India
18
Nepal
18
Syria
18
Latin America and the Carribbean
17
Eastern Europe and Central Asia
17
Russia
16
South Africa
15
Guinea
12
Uganda
12
South–East Asia Region
12
Philippines
11
Bangladesh
11
West and Central Africa
11
Venezuela
11
Rwanda
10
Moldova
10
Zimbabwe
9
Malawi
9
East and Southern Africa
9
Senegal
8
Congo, Democratic Republic of
8
Tanzania
8
Namibia
8
Tajikistan
8
Thailand
7
Indonesia
7
Georgia
7
Burkina Faso
6
South Sudan
6
Jordan
6
Brazil
6
North Macedonia
6
Colombia
6
Middle East and North Africa
6
Cameroon
5
Cambodia
5
Mozambique
5
Eswatini/ Swaziland
5
Yemen
5
Paraguay
5
Asia
5
Albania
5
Haiti
4
Somalia
4
Sudan
4
Benin
4
Hungary
4
Botswana
4
Poland
4
USA
3
Pakistan
3
Afghanistan
3
Lebanon
3
Turkey
3
China
3
Serbia
3
Lesotho
3
Laos
3
Romania
3
Kyrgyzstan
3
Kazakhstan
3
Vietnam
3
Jamaica
3
Belarus
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Iraq
2
Egypt
2
Central African Republic
2
Argentina
2
Bolivia
2
Libya
2
Madagascar
2
Sri Lanka
2
Chile
2
Western Pacific Region
2
Bulgaria
2
Estonia
2
Iran
2
Uzbekistan
2
Bosnia and Herzegovina
2
Mali
1
Saudi Arabia
1
Niger
1
Mauritania
1
Papua New Guinea
1
Peru
1
Ecuador
1
El Salvador
1
Greece
1
Mexico
1
Bhutan
1
Armenia
1
Mongolia
1
Southern Africa
1
Slovakia
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
429
Clinical Guidelines
158
Public Health
97
Women & Child Health
77
Key Resources
72
Pharmacy & Technologies
30
Capacity Building
14
Toolboxes
COVID-19
165
Mental Health
164
HIV
137
TB
125
AMR
110
Planetary Health
82
Conflict
74
Rapid Response
71
Pharmacy
59
Refugee
52
Disability
49
Ebola
47
Global Health Education
42
NCDs
33
Caregiver
31
Health Financing Toolbox
27
NTDs
23
Specific Hazards
18
Natural Hazards
14
Zika
14
Polio
6
Cholera
3
Social Ethics
1
BMJ Global Health Vol.4 (2019 no.4
The Drug Resistance Index (DRI) is proposed as measure of antibiotic effectiveness in a given country, by combining, in a single metric the use of various antibiotic groups and the resistance proportions of several pathogens.It is a complicated measure that gives ...
This FY 2019 Malaria Operational Plan presents a detailed implementation plan for Burkina Faso, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the NMCP and with the participation of national and international partners involved in...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac...
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
A rapid review of evidence on the managing the risk of disease emergence in the wildlife trade - World Animal Health Organization (OIE)
Climate change presents significant challenges to human health and biodiversity. Increased numbers of extreme climate events, such as heat waves, droughts or flooding, threaten human health and well-being, both directly and indirectly, through impaired ecosystem functioning and reduced ecosystem ser...
The biosphere underlies the whole sustainable development concept, as the layer on
which society and the economy rely. Nature and biodiversity fuel the natural cycles
and life-support systems of the planet, on which humanity ultimately depends.
Biodiversity and Health in the Face of Climate Change pp 47–66
This chapter reviews the emerging importance of pollen allergies in relation to ongoing climate change. Allergic diseases have been increasing in prevalence over the last decades, partly as the result of the impact of climate change. ...
This policy paper outlines key health financing policy actions for countries to ensure universal access to health services and financial protection for people fleeing conflict. It focuses on three policy areas – granting entitlement and ensure access to the full range of needed health services for...
Consultancy Report May 2022
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
This publication articulates the WHO Botswana Country Office’s focus and investment needs for the biennium 2022–2023, building on achievements, networks, and partnerships fostered in 2020-2021.
As the leading health authority within the United Nations system in Botswana, the WHO Country Offi...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
